Literature DB >> 27195775

Correction: Topical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats.

Conceição S Martins, Renata F C Leitão, Deiziane V S Costa, Iracema M Melo, Glaylton S Santos, Vilma Lima, Victor Baldim, Deysi V T Wong, Luana E Bonfim, Cíntia B Melo, Marcelo G de Oliveira, Gerly A C Brito.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0153716.].

Entities:  

Year:  2016        PMID: 27195775      PMCID: PMC4873148          DOI: 10.1371/journal.pone.0156356

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Fig 9 was incorrectly duplicated as Figs 8 and 9. Please see the corrected Fig 8 here.
Fig 8

Representative examples of iNOS (1st row), RANK (2nd row) and TRAP (3rd row) immunostaining in experimental periodontitis in rats.

Staining was performed using periodontal tissues from normal control animals (b, g, l, q), animals subjected to experimental periodontitis that received topical applications of HPMC (c, h, m, r) or 10 mM HPMC/GSNO (d, i, n, s). Negative controls were samples of periodontal tissue where the primary antibody was replaced with PBS-BSA (5%); no immunostaining was detected (a, f, k, p). Magnification x200. Arrows points to immunostaining osteoclasts in the periodontal tissue of the control HPMC solution group (Magnification x1000).

Representative examples of iNOS (1st row), RANK (2nd row) and TRAP (3rd row) immunostaining in experimental periodontitis in rats.

Staining was performed using periodontal tissues from normal control animals (b, g, l, q), animals subjected to experimental periodontitis that received topical applications of HPMC (c, h, m, r) or 10 mM HPMC/GSNO (d, i, n, s). Negative controls were samples of periodontal tissue where the primary antibody was replaced with PBS-BSA (5%); no immunostaining was detected (a, f, k, p). Magnification x200. Arrows points to immunostaining osteoclasts in the periodontal tissue of the control HPMC solution group (Magnification x1000).
  1 in total

1.  Topical HPMC/S-Nitrosoglutathione Solution Decreases Inflammation and Bone Resorption in Experimental Periodontal Disease in Rats.

Authors:  Conceição S Martins; Renata F C Leitão; Deiziane V S Costa; Iracema M Melo; Glaylton S Santos; Vilma Lima; Victor Baldim; Deysi V T Wong; Luana E Bonfim; Cíntia B Melo; Marcelo G de Oliveira; Gerly A C Brito
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.